Background {#Sec1}
==========

Diarrheal disease is a leading cause of death in children under five years of age worldwide \[[@CR1]\], and a high proportion of these deaths, approximately 40 %, occur in Africa \[[@CR2]\]; however this population has been rarely studied \[[@CR3]\]. Additionally, infectious diarrhea causes significant morbidity including growth faltering, malnutrition and impaired cognitive development \[[@CR4]\].

Classic human astroviruses (HAstV) are a well-established etiology of viral gastroenteritis, causing approximately 2 % to 8 % of childhood diarrhea in Africa \[[@CR5]--[@CR10]\]. All 8 serotypes of HAstV have been associated with diarrhea. Since 2008, seven highly divergent astroviruses (MLB1, MLB2, MLB3, VA1/HMO-C, VA2/HMO-B, VA3/HMO-A, VA4) have been discovered in human stool samples \[[@CR11]--[@CR16]\]. To date, there have been few prevalence studies and no definitive disease association established for these viruses.

MLB1 was the first of these to be discovered and has been detected in stools across the world including Australia, Asia, Africa, North America and Europe \[[@CR11], [@CR13], [@CR15]--[@CR22]\]. Furthermore a seroepidemiologic study of MLB1 demonstrated that primary exposure occurs in childhood and that seropositivity reached 100 % by adulthood \[[@CR23]\]. One case--control study of MLB1 has been reported of Indian children that did not show an association of MLB1 with diarrhea \[[@CR24]\]. MLB2 was initially discovered in stool, and MLB2 viremia in a febrile child has been described \[[@CR25]\]. MLB3 was described recently in India in 2013 and found in 0.6 % of stools sampled \[[@CR12]\].

VA1/HMO-C was first identified in an unexplained outbreak of gastroenteritis \[[@CR14]\] and has since been detected in the brain of multiple immunocompromised patients with encephalitis \[[@CR26]--[@CR28]\]. This virus has been found to have a seroprevalence of 65 % in adults \[[@CR29]\]. VA2/HMO-A and VA3/HMO-B have been described in stools from Nigeria, Pakistan, and India, while VA2/HMO-A has additionally been found in stools from the United States, China and Egypt \[[@CR11], [@CR13], [@CR18], [@CR21]\]. VA4 was recently discovered in 2 stool samples from Nepal \[[@CR12]\].

Due to the limited data on these novel astroviruses, the objective of this study was to explore the prevalence and diversity of astroviruses in a pediatric population using cases of moderate-severe diarrhea (MSD) and matched controls in Kenya and The Gambia.

Results {#Sec2}
=======

Astroviruses were present in 9.9 % of all samples and represented primarily a mixture of classic, MLB and VA astroviruses (MLB3 2.6 %, HAstV 2.5 %, MLB1 1.7 %) (Table [1](#Tab1){ref-type="table"}). MLB3 was the most prevalent astrovirus, followed by HAstV and MLB1.Table 1Astrovirus Screening ResultsKenyaThe GambiaAll samplesCasesControlspCasesControlspCasesControlspTotaln = 181n = 181n = 266n = 321n = 447n = 502n = 949HAstV740.3270580.460912120.943224MLB1**111[0.0217\*]{.ul}**221.000**133[0.0221\*]{.ul}**16MLB2010.9907270.2722280.180810MLB3160.9864**315[0.0421\*]{.ul}421[0.0071\*]{.ul}**25VA100N/A010.9857010.98571VA2221.0000460.9435680.956914VA300N/A00N/A00N/A0VA400N/A00N/A00N/A0Total^†^2114N/A1639N/A3753N/A90HAstV- Human AstrovirusN/A- Not applicable\*Significant at p \< 0.05^†^Total does not include additional astroviruses including Canine Astrovirus, Avian Nephritis Virus 1 and 2, and VA5

MLB3 was detected more frequently in controls than in diarrhea cases in The Gambia (4.7 % controls vs 1.1 % cases; p = 0.0421) as well as overall (4.2 % controls vs 0.9 % cases; p = 0.0071). Sequencing of the amplicons from the MLB3 positive samples from 6 of 7 Kenyan samples yielded sequences that shared 97-99 % identity with the reference MLB3 strain. However, the seventh Kenyan sample and all 18 positive samples from The Gambia shared only 88--89 % identity to the reference MLB3 strain, demonstrating that a previously unrecognized diversity of MLB3 subtypes exists (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Phylogenetic Analysis of MLB3 amplicons. Amplicons measuring 409 nucleotides in length from ORF 1b were used for phylogenetic analysis. Significant bootstrap values (\>700) are shown. Scale bar represents the number of nucleic acid differences. GenBank accession numbers or sample numbers are listed for reference

MLB1 was significantly associated with diarrhea in Kenya (6.1 % cases vs 0.6 % controls; p = 0.0217). All of the MLB1 positive stools in Kenya occurred in a 4 month timeframe of stool collection between May-August of 2008 with 7 of the 12 positive samples collected within 12 days. By contrast, prevalence of MLB1 was lower in The Gambia, 3 of the 4 detections occurred in March and April, and no association with diarrhea was observed (0.8 % cases vs. 0.6 % controls). There was no difference in the prevalence of classic astroviruses between cases and controls (2.7 % cases vs. 2.4 % controls). VA-clade viruses were detected at low prevalence (VA1 and VA2) or not at all (VA3 and VA4).

The results of previous microbiologic testing for 17 diarrhea pathogens for these samples \[[@CR3]\] were used to determine if any of the known pathogens were detected with any astrovirus more frequently than by chance. Prevalence of *Campylobacter jejuni* infections in the aggregate Kenya and The Gambia population was 4.5 % (5.8 % of cases and 3.4 % of controls) (Table [2](#Tab2){ref-type="table"}). Co-detection of MLB1 and *Campylobacter jejuni* was significant; 5 of the 16 stools positive for MLB1 were also positive for *C. jejuni* (p = 0.0005). All five of the samples with both MLB1 and *C. jejuni* were diarrhea cases.Table 2*Campylobacter jejuni* and MLB1 Co-detectionMLB1 NegativeMLB1 PositiveTotal*Campylobacter* Negative895 (94.3 %)11 (1.2 %)906*Campylobacter* Positive38 (4.0 %)**[5 (0.5 %)\*]{.ul}**43Total93316949\*Co-detection of MLB1 and *Campylobacter jejuni* was significant at p = 0.0005 using Fisher exact test, 95 % CI (2.757--35.260)

Sequencing of the pan-astrovirus primer derived amplicons also yielded several unexpected results. A 415 nucleotide (nt) amplicon \[GenBank: KJ777800\] from a Kenyan case stool shared 95 % nucleotide identity to Canine astrovirus strain 915 \[GenBank: JX878480\]. In addition, a 439 nt amplicon \[GenBank: KJ777802\] from a Kenyan control stool shared 92 % identity to Avian Nephritis Virus 2 \[GenBank: HQ188698\] \[[@CR30]\], while a 439 nt amplicon \[GenBank: KJ777801\] from a Gambian control sample shared 94 % identity to Avian Nephritis Virus 1 \[GenBank: AB033998\] \[[@CR31]\]. Finally, a 433 nt amplicon from a control sample from the Gambia shared only 77 % nucleotide identity to VA4. We sequenced the nearly-complete genome of 6519 nt \[GenBank: KJ656124\], which we tentatively named astrovirus VA5 (Fig. [2](#Fig2){ref-type="fig"}). Further analysis demonstrated that this sequence shared 94 % nucleotide identity to a very recently published sequence Human astrovirus BF34 \[GenBank: KF859964\] \[[@CR32]\]. VA5 contains characteristic astrovirus motifs such as a heptameric slippery sequence (AAAAAAC) and a stem-loop II in the 3′ UTR.Fig. 2Phylogenetic Analysis of Astrovirus ORF2 capsid protein. The complete amino acid sequence from ORF2 was used for phylogenetic analysis. Significant bootstrap values (\>700) are shown. Scale bar represents the number of amino acid differences. ANV: Avian Nephritis Virus

Discussion {#Sec3}
==========

In summary, astroviruses are commonly found in pediatric stool samples in Kenya and The Gambia. While there have been a few reports describing the prevalence of recently identified astroviruses in African countries such as Egypt and Nigeria \[[@CR13], [@CR18]\] there have been no studies from Kenya or The Gambia. Astrovirus MLB3 was recently discovered in India in 2013 \[[@CR12]\] and has not been previously detected in Africa; however, it was the most frequently detected of all of the astroviruses in this study.

This is only the second study reporting MLB3 and the first case--control study of MLB3 performed. Compared to the initial study in India, MLB3 was detected at a prevalence four times higher in Africa \[[@CR12]\]. Furthermore, there is a novel diversity of MLB3 viruses, as a distinct subtype of MLB3 that differed by \> 10 % from the reference MLB3 was detected. Prior studies of the 8 classic human astrovirus serotypes have also shown geographic strain variation \[[@CR33]\].

Interestingly, MLB3 was negatively associated with moderate-severe diarrhea in The Gambia. Although viruses are generally associated with undesirable consequences, a recent animal model showed that enteric viruses may also have beneficial functions \[[@CR34]\]. In the animal model, murine norovirus provided protection against mucosal damage and supported intestinal homeostasis in germ-free and antibiotic-treated mice. The association of MLB3 with the control state, may indicate that MLB3 can similarly provide protection from diarrhea in this population. Alternatively, MLB3 may be a pathogen of another organ system and affected by diarrhea-associated changes in the gut.

There was a positive association between MLB1 and diarrhea in this matched case--control study in Kenya, raising the possibility that MLB1 may play a role in the etiology of diarrhea. However, no association was observed in The Gambia. In Kenya, there was a clustering of positive stools over a 12 day time period. This could indicate an outbreak of MLB1 leading to diarrhea and increased prevalence that was not captured in The Gambia. The association of MLB1 with diarrhea also differed from a prior case--control study in India \[[@CR24]\]. Although the aggregate analysis of Kenya and The Gambia together still yields a statistically significant association with diarrhea overall (p = 0.0221), the different results from the two sites renders it difficult to make definitive conclusions.

Clearly the two geographic sites yielded distinct prevalence rates for both MLB1 and MLB3. Geographic variation of eukaryotic viruses occurs \[[@CR35]\] and likely contributed to our findings. These observations underscore the need for additional studies in diverse geographic sites to better define the prevalence of these novel astroviruses.

This study showed a significant association between MLB1 and *C. jejuni. Campylobacter* is typically a food-borne or zoonotic disease \[[@CR36]\], while classic human astrovirus is most commonly transmitted by human to human contact \[[@CR33]\]. Although the route of transmission of MLB1 is currently unknown, the high rate of co-detection could be due to similar transmission of MLB1 and *Campylobacter* through food or water. Previous studies have shown that mixed infections with *Campylobacter* and other pathogens are common \[[@CR37], [@CR38]\], and specific virus-induced cell alterations enhanced the invasiveness of *C. jejuni* in a cell culture model \[[@CR39]\]. These observations raise the question of whether there may be synergistic effects between these agents and whether those effects play a role in the etiology of diarrhea, as all co-detections occurred in cases with diarrhea.

Although HAstV is a well-established cause of diarrhea, it was not associated with moderate-severe diarrhea in this study. This observation may be due to the exclusion of mild cases of diarrhea typically associated with HAstV infection. This result also reflects some of the challenges of using the case--control approach for disease attribution as other well-defined human diarrhea pathogens have also failed in single case--control studies \[[@CR40], [@CR41]\].

Unexpectedly, there were sequences in human stool with high identity to Avian Nephritis Virus 1 and 2 and Canine Astrovirus. These observations may be the result of ingestion of infected meat, as this phenomenon has been described for plant viruses \[[@CR17], [@CR42]\] or may be related to environmental exposure to animals. Zoonotic infection has been postulated to occur in astroviruses due to the frequent occurrence of recombination events and wide range of species infected \[[@CR43]\] and is another possibility. In addition, a novel astrovirus VA5, similar to the recently reported HAstV-BF34 was identified \[[@CR32]\]. It was only the use of broadly reactive PCR primers in this study that enabled the detection of these unexpected or novel agents. Prior studies of the prevalence of classic HAstV used primers that targeted specifically Human Astroviruses 1--8. Those primers could not detect viruses such as Avian Nephritis Virus or Canine Astrovirus. With the dramatic increase the number of astrovirus species discovered, further optimization of consensus astrovirus primers and their application to analyze human cohorts may uncover much more about the types and frequency of astroviruses found in human stool.

Conclusions {#Sec4}
===========

In conclusion, astroviruses including the novel MLB- and VA-clades are commonly found in pediatric stools in Kenya and The Gambia and a wide range of astroviruses was detected in this population. One of the most recently discovered astroviruses, MLB3 was also the most prevalent. MLB1 was associated with diarrhea in Kenya, while MLB3 was found more commonly in the control stools in The Gambia. There is diversity within the species of MLB3. Unexpected animal astrovirus species were detected in human stool through the use of broadly reactive PCR primers. Additional studies are needed to better understand the role of these novel astroviruses in human health and disease.

Methods {#Sec5}
=======

Samples {#Sec6}
-------

This investigation utilized 949 stool samples from cases of moderate-severe diarrhea and matched controls aged 0--59 months participating in the Global Enteric Multicenter Study (GEMS) at two rural sites in Kenya and The Gambia \[[@CR3]\]. Samples were collected from Kenya between April 2008 and December 2008 and from The Gambia between March 2008 and April 2009. The study was approved by ethics committees at the University of Maryland, Baltimore, MD, USA, and at both field sites.

Cases of moderate-severe diarrhea were defined as acute (onset within 7 days) with ≥ 3 loose stools within 24 hours and 1 of the following criteria: sunken eyes, loss of skin turgor, intravenous hydration prescribed, dysentery, or admission to hospital. For every enrolled case, one to three matched control children was enrolled. Controls were matched to every case by age (±2 months for patients aged 0--23 months and ±4 months for patients aged 24--59 months), sex and residence (same or nearby village as the patient with diarrhea) (Table [3](#Tab3){ref-type="table"}). Controls were enrolled within 14 days of the index case and were excluded if they had diarrhea in the prior 7 days. All stools were previously screened for an array of bacterial, parasitic, and viral pathogens \[[@CR44]\].Table 3Patient DemographicsKenyaThe GambiaAll samplesCasesControlspCasesControlspCasesControlspTotaln = 181n = 181n = 266n = 321n = 447n = 502n = 949Age (mos)17.417.50.98516.418.00.062616.817.80.21217.1Gender (M)55.8 %55.8 %1.00056.4 %55.5 %0.82056.2 %55.6 %0.85955.8 %

In total, 362 stools from Kenya (181 cases, 181 controls) and 587 stools from The Gambia (266 cases, 321 controls) were available for analysis. A Welch two sample *t*-test was used to examine for differences in age between cases and controls. To assess for differences in gender between cases and controls a chi square test was performed. To determine if presence of specific astroviruses was associated with diarrhea a conditional logistic regression was performed. To analyze if there were significant co-infections with astroviruses and other known pathogens Fisher exact test was used. P values \<0.05 were determined to be significant. All statistical analyses were done in SAS 9.3 (Carey, NC).

Screening {#Sec7}
---------

RT-PCR screening of nucleic acid extracted from stool filtrates was performed using a one-step kit (Qiagen) with pan-astrovirus primers SF0073 (5′-GATTGGACTCGATTTGATGG-3′) and SF0076 (5′-CTGGCTTAACCCACATTCC-3′) that target the RNA-dependent RNA polymerase as previously described \[[@CR11]\]. Positive samples were then screened using primers designed to target the capsid region of classic human astroviruses \[Mon269 (5′-CAACTCAGGAAACAGGGTGT-3′) and Mon270 (5′-TCAGATGCATTGTCATTGGT-3′)\] and MLB1 \[SF0053 (5′-CTGTAGCTCGTGTTAGTCTTAACA-3′) and SF0061(5′-GTTCATTGGCACCATCAGAAC-3′)\] \[[@CR11]\]. Pan-astrovirus derived amplicons from samples negative in both secondary screens were cloned into pCR4-TOPO vector (Invitrogen) and Sanger sequenced. Sequences were compared to the GenBank nr/nt database on May 7, 2014 and deposited \[Genbank: KJ807476 to KJ807529, KJ777800 to KJ777802\].

Full genome sequencing {#Sec8}
----------------------

Deep-sequencing was performed on the stool sample containing the newly described virus VA5 using the Roche Titanium FLX platform \[[@CR14]\]. 1004 viral reads were identified using Virushunter \[[@CR45]\] and assembled using Newbler generating a contig of 6519 nucleotides. The contig was confirmed by RT-PCR and 3′ rapid amplification of cDNA ends. The complete 5′ UTR was not successfully sequenced after multiple attempts. This 6519 base pair sequence was deposited in Genbank \[Genbank: KJ656124\].

Phylogenetic analysis {#Sec9}
---------------------

MLB3 nucleic acid amplicon sequences were aligned and maximum-likelihood trees were created by CLUSTALX version 2.1 with 1000 bootstrap replicates. Phylogenetic analysis of the recently described VA5 was performed by aligning amino acid sequences from the complete ORF2 with MUSCLE. Best-fit model was determined using Prottest (version 2.4) \[[@CR46]\], and maximum-likelihood trees were generated using Phyml (version 3.0) \[[@CR47]\].

Accession numbers for astrovirus sequences used in Fig. [2](#Fig2){ref-type="fig"} are as follows: Turkey Astrovirus 1: CAB95007; Turkey Astrovirus 2: NP987088; Turkey Astrovirus 3: AAV37187; Duck Astrovirus: ACN82429; Guinea Fowl Astrovirus: JN985815; Chicken Astrovirus 1: NP620618; Chicken Astrovirus 2: BAB21617; Avian Nephritis Virus 1: HM029238; Avian Nephritis Virus 2: AEB15604; Pigeon Astrovirus: CBY02488; Rabbit Astrovirus: AEV92822; Astrovirus MLB1: YP002290968; Astrovirus MLB2: YP004934010; Astrovirus MLB3: JX857870; Canine Astrovirus: AEX00102; Dog Astrovirus: ADL27736; DogBari Astrovirus: HM045005; Sealion Astrovirus 1: ACR54272; Sealion Astrovirus 2: ACR54274; Sealion Astrovirus 4: JN420351; Sealion Astrovirus 5: JN420352; Sealion Astrovirus 6: JN420353; Sealion Astrovirus 9: JN420356; Porcine Astrovirus: BAA90309; Porcine Astrovirus 2: AER30006; Porcine Astrovirus 3: NC019494; Porcine Astrovirus 4: JF713713; Porcine Astrovirus 5: JF713711; Swine Astrovirus: ADV16836; Feline Astrovirus 1: AAC13556; Feline Astrovirus 2: NC022249; Human Astrovirus 1: NP059444; Human Astrovirus 2: L13745; Human Astrovirus 3: AAD17224; Human Astrovirus 4: AAY84779; Human Astrovirus 5: AAY46274; Human Astrovirus 6: CAA86616; Human Astrovirus 7: AAK31913; Human Astrovirus 8: AAF85964; Dolphin Astrovirus 1: ACR54280; Dolphin Astrovirus 3: HQ668129; Whale Astrovirus 2: HQ668143; Bat Astrovirus AFCD337: ACF75865; Bat Astrovirus LC03: ACN88720; Bat Astrovirus LD38: ACN88708; Bat Astrovirus LD71: ACN88712; Ovine Astrovirus: CAB95004; Astrovirus VA1: NC013060; Astrovirus VA2: GQ502193; Astrovirus VA3: JX857868; Astrovirus VA4: JX857869; Astrovirus VA5: KJ656124; Fox Astrovirus: KC692365; Mink Astrovirus: NP795336; Bovine Astrovirus B76: AED89609; Deer Astrovirus 1: HM447045; Deer Astrovirus 2: HM447046; Wild boar Astrovirus: AEZ67026; Murine Astrovirus: NC018702; Rat Astrovirus: HM450382.
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